Markel unveils new insurance product for clinical trials
The new offering provides insurance cover for sponsors, researchers and participants across all phases of clinical trials.
| Ticker |
MKL
|
| CIK | 0001096343 |
| SIC | 6331 |
| Sector | Finance, Insurance, And Real Estate |
| Industry Category | Insurance |
| Industry Group | Fire, Marine & Casualty Insurance |
| Address | 4521 HIGHWOODS PARKWAY, GLEN ALLEN, VA, 23060-6148 |
| Website | markel.com |
| Phone | 8047470136 |
| CEO | Richard R. Whitt |
| Employees | 20,900 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Markel unveils new insurance product for clinical trialsThe new offering provides insurance cover for sponsors, researchers and participants across all phases of clinical trials. Markel Group announces redemption of Series A Preferred SharesMarkel Group Inc. (NYSE: MKL) will redeem for cash all of its outstanding Series A 6.000% Fixed-Rate Reset Non-Cumulative Preferred Shares, no par value (the Series A Preferred Shares), effective June 1, 2025 (the Redemption Date) at a price of $1,000 per share, which is equal to the per-share liquidation preference of the Series A Preferred Shares. Since the Redemption Date is not a business day, the redemption will be processed on June 2, 2025. There are currently 600,000 Series A Preferred Sh Markel Group Inc. (MKL): A Bull Case TheoryWe came across a bullish thesis on Markel Group Inc. (MKL) on Substack by Value Don’t Lie. In this article, we will summarize the bulls’ thesis on MKL. Markel Group Inc. (MKL)’s share was trading at $1813.28 as of April 28th. MKL’s trailing and forward P/E were 9.10 and 12.71 respectively according to Yahoo Finance. Markel Corporation, […] Markel launches Clinical Trials products to support clinical trials research, globallyMarkel Insurance, the insurance operations within Markel Group Inc. (NYSE: MKL), today announced the launch of its Clinical Trials insurance product – underscoring its commitment to providing best-in-class solutions to support clinical trials research and product development on an international scale. Markel launches Clinical Trials products to support clinical trials research, globallyMarkel Insurance, the insurance operations within Markel Group Inc. (NYSE: MKL), today announced the launch of its Clinical Trials insurance product – underscoring its commitment to providing best-in-class solutions to support clinical trials research and product development on an international scale. |